9 completed, 3 recruiting. 7 Phase 1, 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 6, Recruiting 1 |
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Pneumococcal Infectious Disease: new trials by email Literature Review of Pneumococcal Infectious Disease trials Research Report on Pneumococcal Infectious Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years Sinovac PCV24, Prevnar® - Pneumococcal Infectious Disease | Phase 2 | Recruiting | Sinovac Life Sciences Co., Ltd. | 420 | 2025-11-25 | 2025-12-24 |
| PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months 24-Valent Pneumococcal Polysaccharide Conjugate Vaccine (RZ700), 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (Prevnar 13) - Pneumococcal Infectious Disease | Phase 2 | Completed | Reinovax Biologics Co., LTD | 480 | 2025-09-11 | 2026-07-27 |
| Clinical Trial of PCV24 in Adults Aged ≥18 Years Sinovac Low-dosage PCV24, Sinovac Middle-dosage PCV24, Sinovac High-dosage PCV24 - Pneumococcal Infectious Disease | Phase 1 / Phase 2 | Completed | Sinovac Life Sciences Co., Ltd. | 385 | 2025-06-18 | 2026-04-21 |
| Clinical Trial of PCV24 in Infants Aged 2-23 Months Sinovac PCV24, Prevnar® - Pneumococcal Infectious Disease | Phase 1 | Recruiting | Sinovac Life Sciences Co., Ltd. | 180 | 2025-05-08 | 2026-01-28 |
| Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine Sinovac PCV13, Prevnar® - Pneumococcal Infectious Disease | Phase 3 | Recruiting | Sinovac Life Sciences Co., Ltd. | 3080 | 2024-10-23 | 2026-01-28 |
| Clinical Trial of PCV24 in Children Aged 2-17 Years Sinovac PCV24 formulation 1, Sinovac PCV24 formulation 2, Prevenar13® - Pneumococcal Infectious Disease | Phase 1 | Completed | Sinovac Life Sciences Co., Ltd. | 119 | 2024-09-07 | 2026-01-28 |
| Clinical Trial of PCV24 in Adults Sinovac PCV24 formulation 1, Sinovac PCV24 formulation 2, Pneumovax® - Pneumococcal Infectious Disease | Phase 1 | Completed | Sinovac Life Sciences Co., Ltd. | 170 | 2024-06-21 | 2025-04-16 |
| Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years PCV24 formulation 1, PCV24 formulation 2, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine - Pneumococcal Infectious Disease | Phase 1 | Completed | Reinovax Biologics Co., LTD | 230 | 2024-04-27 | 2026-08-17 |
| Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine Reinovax PCV24 formulation 1, Reinovax PCV24 formulation 2, Reinovax PCV24 formulation 3 - Pneumococcal Infectious Disease | Phase 2 | Completed | Reinovax Biologics Co., LTD | 992 | 2024-04-20 | 2026-08-17 |
| A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine Sinovac PCV13, PREVNAR 13 - Pneumococcal Infectious Disease | Phase 1 | Completed | Sinovac Research and Development Co., Ltd. | 140 | 2024-01-04 | 2026-01-28 |
| Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older Reinovax PCV24 formulation 1, Reinovax PCV24 formulation 2, PPSV23 - Pneumococcal Infectious Disease | Phase 1 | Completed | Reinovax Biologics Co., LTD | 240 | 2023-11-19 | 2024-11-07 |
| A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population 23-valent pneumococcal polysaccharide vaccine, Influenza vaccine - Pneumococcal Infectious Disease | Completed | Sinovac Biotech Co., Ltd | 19267 | 2022-07-02 | 2025-07-17 |
Bacterial Infections (12) · Bacterial Infections and Mycoses (12) · Gram-Positive Bacterial Infections (12) · Infections (12) · Streptococcal Infections (12)
13-valent pneumococcal vaccine (4) · 23-valent pneumococcal capsular polysaccharide vaccine (3) · Heptavalent Pneumococcal Conjugate Vaccine (3) · Pneumococcal Vaccines (2) · Influenza Vaccines (1) · Sodium Chloride (1)
Sinovac Life Sciences Co., Ltd. (6) · Reinovax Biologics Co., LTD (4) · Sinovac Biotech Co., Ltd (1) · Sinovac Research and Development Co., Ltd. (1)
China (12)
Kai Chu (2) · Yunong Zhang, Master (2) · Qing Xu (1) · Weijun Hu (1) · Yan Zheng (1) · Yanxia Wang (1)